Model Driven Patient Selection Using Eye-Tracking Features for Improved Efficacy in a Phase 2 Trial in Autism Spectrum Disorder With JNJ-42165279, a Fatty Acid Amide Hydrolase (FAAH) Inhibitor

NEUROPSYCHOPHARMACOLOGY(2023)

引用 0|浏览0
暂无评分
关键词
Predictive Biomarker,Eye Tracking,Autism Spectrum,Disorders
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要